Which data are available in central registries on bladder cancer patients in the five Nordic countries.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsKörner, Stefanie Korsgaard
Haug, Erik Skaaheim
Boström, Peter J
Jensen, Jørgen Bjerggaard
MetadataShow full item record
CitationKörner SK, Dreyer T, Haug ES, Jerlström T, Boström PJ, Gudjonsson S, Jensen JB. Which data are available in central registries on bladder cancer patients in the five Nordic countries. Scand J Urol. 2021 Jan 28:1-7. doi: 10.1080/21681805.2021.1877344.
AbstractObjective: The aim of this study was to give a collective overview on all available data sources on bladder cancer patients in the Nordic countries including the amount of detail and coverage. Methods: National representatives from five Nordic countries were asked to fill out a questionnaire on available information regarding bladder cancer patients from databases in their respective countries. Additional information was retrieved from descriptions of the relevant registries. Results: Non-muscle invasive bladder cancer: from all countries, information on stage and grade at transurethral resection of the bladder (TURB) could be retrieved. Details on procedures (TURB, instillation therapy, photodynamic diagnosis, and perioperative instillation) were varying within different databases. Muscle invasive bladder cancer: in all Nordic countries, detailed information on cystectomy patients could be retrieved but with variable registration of complications. Completeness of available information on oncological treatment (radiation, chemotherapy, and immunotherapy) were varying. Oncological outcome: Information on overall survival was available in all countries whereas recurrence-free survival and cancer-specific survival were available for some but not all patients depending on treatment modality. Conclusions: Despite limitations, we found that it was possible to retrieve detailed information on diagnostics, treatment, and outcome for most aspects of bladder cancer in the Nordic countries on a population based, non-selected patient cohort. Keywords: Bladder cancer; database; muscle invasive; non-muscle invasive; registry.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
- Bladder sparing surgery in high-grade bladder cancer.
- Authors: Yakovlev PG, Klyushin DA, Vereshchako RI
- Issue date: 2019 Jun
- Intravesical gemcitabine for non-muscle invasive bladder cancer.
- Authors: Jones G, Cleves A, Wilt TJ, Mason M, Kynaston HG, Shelley M
- Issue date: 2012 Jan 18
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
- Authors: Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Escrig JLD, Hernández V, Peyronnet B, Seisen T, Soukup V
- Issue date: 2019 Nov
- Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
- Authors: Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T, Cancer Registration Committee of the Japanese Urological Association.
- Issue date: 2009 Mar
- EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
- Authors: Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, Hernández V, Kaasinen E, Palou J, Rouprêt M, van Rhijn BWG, Shariat SF, Soukup V, Sylvester RJ, Zigeuner R
- Issue date: 2017 Mar